| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Parrette Leslie J, Director
Bought 345 shares ($27.5K) |
| 04 Nov 2026 | 10-Q |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Continued strength in Fuel Specialties; Double-digit operating income growth in Performance Chemicals and Oilfield Services |
| 07 Oct 2026 | SCHEDULE 13G/A |
| 07 Oct 2026 | SCHEDULE 13G |
| 05 Oct 2026 |
Form 4: Barnes Corbin, SVP, Corporate Dev and IR
Granted 2,642 Phantom Stock |
| 05 Oct 2026 |
Form 4: Griffin Hardy Louis Iii, SVP, HUMAN RESOURCES
Granted 2,685 Phantom Stock |
| 05 Oct 2026 |
Form 4: Cleminson Ian, EVP & CFO
Granted 4,792 Phantom Stock |
| 05 Oct 2026 |
Form 4: Mcrobbie Ian Malcolm, Senior VP R&T
Granted 3,164 Phantom Stock |
| 05 Oct 2026 |
Form 4: Jones David B., SVP, GC & CCO
Granted 3,188 Phantom Stock |
| 05 Oct 2026 |
Form 4: Williams Patrick, PRESIDENT & CEO
Granted 22,203 Phantom Stock |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
Englewood, CO – August 4, 2026 – Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the second quarter ended June 30, 2026. |
| 31 Jul 2026 | SCHEDULE 13G/A |
| 14 Jul 2026 | SCHEDULE 13G |
| 01 Jul 2026 |
Form 3: Bausch Shelley J, Director
No securities owned |
| 04 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Effective June 2, 2026, the Board of Directors (“Board”) of Innospec Inc. (the “Company”), in accordance with the Amended and Restated By-Laws of the Company (i) increased the number of directors of the Company from seven (7) to eight (8... |
| 29 May 2026 | SD |
| 13 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Innospec Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (“Annual Meeting”) on May 8, 2026. As of March 13, 2026, the record date for the Annual Meeting, there were 24,890,467 shares of Common Stock of the Company outst... |
| 08 May 2026 | 10-Q |
Loading...